Long-COVID improves in 50% of patients after a year in a Midwestern cohort
Stalker, G.; Tudas, R.; Garg, A.; Graham, L.; Thurman, A.; Wiblin, R. T.; Hamzeh, N.; Blount, R.; Villacreses, R.; Zabner, J.; Comellas, A.; Cho, J.; Pezzulo, A.
Show abstract
BackgroundMany of those infected with COVID-19 experience long-term disability due to persistent symptoms known as Long-COVID, which include ongoing respiratory issues, loss of taste and smell, and impaired daily functioning. Research QuestionThis study aims to better understand the chronology of long-COVID symptoms. Study Design and MethodsWe prospectively enrolled 403 adults from the University of Iowa long-COVID clinic (June 2020 to February 2022). Participants provided symptom data during acute illness, symptom progression, and other clinical characteristics. Patients in this registry received a survey containing questions including current symptoms and status since long-COVID diagnosis (sliding status scale, PHQ2, GAD2, MMRC). Those >12 months since acute-COVID diagnosis had chart review done to track their symptomology. ResultsOf 403 participants contacted, 129 (32%) responded. The mean age (in years) was 50.17 +/-14.28, with 31.8% male and 68.2% female. Severity of acute covid treatment was stratified by treatment in the outpatient (70.5%), inpatient (16.3%), or ICU (13.2%) settings. 51.2% reported subjective improvement (sliding scale scores of 67-100) since long-COVID onset. Ages 18-29 reported significantly higher subjective status scores. Subjective status scores were unaffected by severity. 102 respondents were >12 months from their initial COVID-19 diagnosis and were tracked for longitudinal symptom persistence. All symptoms tracked had variance (mean fraction 0.58, range 0.34-0.75) in the reported symptoms at the time of long-COVID presentation when compared with patient survey report. 48 reported persistent dyspnea, 23 (48%) had resolved it at time of survey. For fatigue, 44 had persistence, 12 (27%) resolved. InterpretationOverall, 51.2% respondents improved since their long-COVID began. Pulmonary symptoms were more persistent than neuromuscular symptoms (anosmia, dysgeusia, myalgias). Gender, time since acute COVID infection, and its severity didnt affect subjective status or symptoms. This study highlights recall bias that may be prevalent in other long-COVID research reliant on participant memory.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High proportion of post-acute sequelae of SARS-CoV-2 infection in individuals 1-6 months after illness and association with disease severity in an outpatient telemedicine population 96%
- Demographic disparities in clinical outcomes of COVID-19: data from a statewide cohort in South Carolina 96%
- Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection 95%
Similar papers in this journal
- Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): a longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection 95%
- Burden of Post-COVID-19 Syndrome and Implications for Healthcare Service Planning: A Population-based Cohort Study 93%
- Diagnostic Value of Symptoms for Pediatric SARS-CoV-2 Infection in a Primary Care Setting 93%
Similar papers in this journal
- Research Letter: Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave 91%
- Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19 89%
- Understanding the patterns of repeated testing for COVID-19: Association with patient characteristics and outcomes 87%
Similar papers in this journal
- Post-COVID assessment in a specialist clinical service: a 12-month, single-centre analysis of symptoms and healthcare needs in 1325 individuals 93%
- Patient symptoms and experience following COVID-19: results from a UK wide survey 91%
- Psychometric analysis of the modified Covid-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study 91%
Similar papers in this journal
- The Validity of the Parsley Symptom Index: an e-PROM designed for Telehealth 89%
- Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers 88%
- Development of the NeuroFlow Severity Score and Comparison With Validated Measures for Depression and Anxiety 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.